Business
Omron's latest investment comes as Sky Labs' ring-type BP monitor expands to consumer use, backed by clinical validation, reimbursement, and new integration with Kakao Healthcare.
Future Cardia's implantable cardiac monitoring device, which is awaiting FDA approval, aims to provide long-term ECG data for rhythm assessment.
The acquisition will integrate CIMAR’s cloud-native infrastructure and services with DeepHealth’s informatics and population health applications.
The unicorn surgical robotics maker will use the funds to further expand into China and overseas while developing new products.
The company recently presented clinical data at the European Society for Medical Oncology Congress for an investigational drug that displayed anti-tumor activity and a good safety profile.
Tom Gillette, Mount Sinai Medical Center's CIO, discusses how Spanish-language AI, predictive models and remote patient monitoring are boosting patient engagement and care access for its diverse South Florida community.
Daryl Tol, president of General Catalyst’s Health Assurance Transformation Company (HATCo), shares an update on the current state of the venture firm’s healthcare system.
The funds will be used to further invest in its product innovation, including its Polaris Safety Constellation Architecture, and to merge with or purchase other companies.
The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials and commercialization of its BCI.
Government regulation can slow health systems' AI progress; Ed Marx, Marx Advisory CEO, says showing policymakers AI's real-world benefits in person can help them understand its value more than traditional lobbying.